Twenty female 6- to 8-week-old NOD-SCID mice were injected subcutaneously (s.c.), into the right flank, with 1×107 RPMI-8226 cells suspended in 200 mL RPMI-1640 medium and 200 mL MatrigelTM as described previously16 (link) and detailed in the Online Supplementary Methods.
Modeling Multiple Myeloma Tumors in Mice
Twenty female 6- to 8-week-old NOD-SCID mice were injected subcutaneously (s.c.), into the right flank, with 1×107 RPMI-8226 cells suspended in 200 mL RPMI-1640 medium and 200 mL MatrigelTM as described previously16 (link) and detailed in the Online Supplementary Methods.
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Universitätsklinikum Würzburg, University of Bari Aldo Moro, Istituto Tumori Bari, Istituti di Ricovero e Cura a Carattere Scientifico, University of Pavia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, University Hospital Schleswig-Holstein, University of Lübeck, Kiel University, Tufts University, Tumori Foundation, University of Würzburg, Istituto Oncologico Romagnolo
Variable analysis
- Anti-JAM-A monoclonal antibody treatment
- Injection method (intratibial, subcutaneous)
- Tumor growth/progression
- Mouse strain (NOD.CB17-Prkdcscid/NCrHsd mice, also known as NOD-SCID)
- Mouse age (8-10 weeks old, 6-8 weeks old)
- Cell line (RPMI-8226)
- Cell suspension (phosphate-buffered saline, RPMI-1640 medium and Matrigel)
- Positive control: None mentioned
- Negative control: None mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!